Nuzenio

Orchestra Biomed Reports

Orchestra Biomed Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 10 Aug 2026 23:22:38 GMTOrchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.tradescanx.trade · Mon, 10 Aug 2026 22:38:50 GMTOrchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 21:55:06 GMTOrchestra BioMed reports Q2 EPS (37c), consensus (38c) - TipRanksTipRanks · Mon, 10 Aug 2026 21:28:08 GMTOrchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeatMarketBeat · Mon, 10 Aug 2026 21:19:02 GMTOrchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend - Stock TitanStock Titan · Mon, 10 Aug 2026 20:22:02 GMTOrchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 20:12:00 GMTIMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 20:09:45 GMT

Timeline

Mon, 10 Aug 2026 23:22:38 GMTOrchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Mon, 10 Aug 2026 22:38:50 GMTOrchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.trade
Mon, 10 Aug 2026 21:55:06 GMTOrchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Mon, 10 Aug 2026 21:28:08 GMTOrchestra BioMed reports Q2 EPS (37c), consensus (38c) - TipRanks
Mon, 10 Aug 2026 21:19:02 GMTOrchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Mon, 10 Aug 2026 20:22:02 GMTOrchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Orchestra Biomed Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.